An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion
· finance.yahoo.com
Bousbib exercised expiring stock appreciation rights while maintaining about 1.4 million shares in total beneficial ownership.
IQVIA serves pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare organizations across the Americas, Europe, Africa, and ...